期刊文献+

庆大霉素联合肝素钠封管在预防中心静脉导管感染中的临床研究 被引量:7

Sealing Tubes with Gentamicin and Heparin Sodium for Prevention of Central Venous Catheter Infection
下载PDF
导出
摘要 目的探讨庆大霉素联合肝素封管在预防中心静脉导管感染中的应用。方法选取经中心静脉导管进行血液净化的100例患者为研究对象,按封管方法的不同分为研究组与对照组,每组50例。对照组采用常规肝素钠2.5mL封管,研究组采用庆大霉素0.25mL联合肝素钠2.25mL封管。随访3个月,比较2组导管感染率及封管后感染发生的时间。结果研究组导管感染率为4%(2/50),低于对照组的18%(9/50)(P<0.05);研究组封管后感染发生的时间为(32.1±3.1)d,晚于对照组的(30.8±2.5)d(P<0.05)。结论使用庆大霉素联合肝素钠封管能降低导管感染率,且能推迟导管感染的时间。 Objective To investigate the application of sealing tubes with gentamicin and heparin sodium in the prevention of central venous catheter infection. Methods One hundred patients undergoing hemodialysis through temporary central venous catheters were randomly divided into two groups,with 50 patients in each group. Thbes were sealed with heparin sodium (2.5 mL) in control group and combined gentamicin (0. 25 mL) and heparin sodium (2.25 mL) in experimental group. After 3 months of follow-up,catheter infection rate and infection time were compared between the two groups. Results Catheter infection rate in experimental group (4%, 2/50) was significantly lower than that in control group (18%,9/50)(P〈0.05). In addition, infection time in experimental group [(32.1±3.1)days] was later than that in control group[(30. 8±2.5) days](P〈0. 05). Conclusion Sealing tubes with gentamicin and heparin sodium can reduce catheter infection rate and delay catheter infection time.
出处 《南昌大学学报(医学版)》 CAS 2013年第9期57-58,72,共3页 Journal of Nanchang University:Medical Sciences
关键词 庆大霉素 肝素 封管 中心静脉导管 导管感染 gentamicin heparin sodium sealing tubes central venous catheter catheter infection
  • 相关文献

参考文献10

二级参考文献96

共引文献197

同被引文献97

  • 1欧阳凌霞,陈江华,何强,郑海斌,张萍,吕蓉.庆大霉素联合肝素作为透析导管封管液稳定性的观察[J].中国中西医结合肾病杂志,2006,7(11):646-648. 被引量:9
  • 2戎殳,叶朝阳,孙丽君,陈静,张斌,梅长林.46.7%枸橼酸钠溶液在血液透析患者长期留置导管封管的应用[J].中华肾脏病杂志,2007,23(2):110-112. 被引量:28
  • 3李海波,候洁,高伟,马立民,陈宝龙,李兰,徐捷.抗生素加肝素混合液封管预防中心静脉置管感染价值[J].中国血液净化,2007,6(5):286-288. 被引量:29
  • 4CORR 2010 CORR Report - Treatment of End - Stage Organ Failure in Canada, 1999 to 2008,2010.
  • 5Lok CE, Mokrzycki MH. Prevention and management of catheter -related infectionin hemodialysis patients. Kidney Int,2011,79 (6) :587 -598.
  • 6Snaterse M, Ruger W, Schohe OP, et al. Antibiotic - based cath- eter lock solutions for prevention of catheter - related blood- stream infection: a systematic review of randomised controlled trials. J Hosp Infect,2010,75 ( 1 ) : 1 - 11.
  • 7Landry DL, Sweet SJ, Gobeille SL, et al. Long - term gentamicin lock catheter prophylaxis is associated with with gentamicin - resistant Gram - positive baeteremias in chronic hemodialysis (abstract). J Am Soc Nephro1,2009,20 ( 12 ) : 2604 - 2615.
  • 8Vascular Access Work Group. Clinical practice guide- lines for vascular access[J].American Journal of Kidney Diseases, 2006, 48 (Suppl):248-274.
  • 9Lok CE, Mokrzycki MH. Prevention and management of catheter-related infectionin hemodialysis patients [J].Kidney international, 2011, 79:587-598.
  • 10Donlan RM. Biofilm formation: a clinically relevant microbiological process[J].Clin Infect Dis, 2001, 33:1387-1392.

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部